To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.

Completed · Phase 3

Conditions studied: Seizure Disorder, Partial

In brief

To evaluate the long-term safety and tolerability of pregabalin in patients with partial seizures.

Key facts

Study ID

NCT00141336

Run by

Pfizer

People needed

750

Starts

1999-11-01

Expected to finish

2005-07-01

Last updated by the study team

2007-01-01

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Must have met the inclusion criteria for preceding double-blind study
• Have received double-blind study medication and wish to receive open-label pregabalin.

You may not qualify if…

• Cannot have absence seizures

Where it is running

• Pfizer Investigational Site — Tucson, Arizona, United States
• Pfizer Investigational Site — Bakersfield, California, United States
• Pfizer Investigational Site — Berkeley, California, United States
• Pfizer Investigational Site — Concord, California, United States
• Pfizer Investigational Site — Covina, California, United States
• Pfizer Investigational Site — El Cajon, California, United States
• Pfizer Investigational Site — Encino, California, United States
• Pfizer Investigational Site — La Mesa, California, United States
• Pfizer Investigational Site — Marina Del Ray, California, United States
• Pfizer Investigational Site — Martinez, California, United States
• Pfizer Investigational Site — Northridge, California, United States
• Pfizer Investigational Site — Pinole, California, United States
• Pfizer Investigational Site — Redondo Beach, California, United States
• Pfizer Investigational Site — Sacramento, California, United States
• Pfizer Investigational Site — Sacramento, California, United States
• Pfizer Investigational Site — San Diego, California, United States
• Pfizer Investigational Site — Santa Monica, California, United States
• Pfizer Investigational Site — Walnut Creek, California, United States
• Pfizer Investigational Site — Denver, Colorado, United States
• Pfizer Investigational Site — Englewood, Colorado, United States
• Pfizer Investigational Site — Danbury, Connecticut, United States
• Pfizer Investigational Site — Miami, Florida, United States
• Pfizer Investigational Site — Miami, Florida, United States
• Pfizer Investigational Site — Orlando, Florida, United States
• Pfizer Investigational Site — Phoenix, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.